Insider Selling: Grail, Inc. (NASDAQ:GRAL) CEO Sells 7,625 Shares of Stock

Grail, Inc. (NASDAQ:GRAL) CEO Robert P. Ragusa sold 7,625 shares of the firm’s stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $31.21, for a total transaction of $237,976.25. Following the transaction, the chief executive officer now directly owns 828,662 shares of the company’s stock, valued at $25,862,541.02. The trade was a 0.91 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Grail Stock Down 12.7 %

GRAL opened at $26.92 on Friday. The firm’s 50-day simple moving average is $31.60 and its 200-day simple moving average is $21.19. Grail, Inc. has a twelve month low of $12.33 and a twelve month high of $63.99.

Grail (NASDAQ:GRAL) last released its quarterly earnings results on Thursday, February 20th. The company reported ($1.86) EPS for the quarter, beating analysts’ consensus estimates of ($4.41) by $2.55. The firm had revenue of $38.25 million during the quarter, compared to analyst estimates of $35.33 million. Equities analysts expect that Grail, Inc. will post -15.15 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Grail

A number of large investors have recently bought and sold shares of GRAL. FNY Investment Advisers LLC bought a new position in Grail in the 4th quarter valued at $26,000. Lindbrook Capital LLC acquired a new stake in shares of Grail in the fourth quarter valued at $28,000. State of Tennessee Department of Treasury bought a new position in shares of Grail in the fourth quarter valued at about $28,000. Sterling Capital Management LLC acquired a new position in Grail during the 4th quarter worth about $29,000. Finally, Wellington Shields Capital Management LLC bought a new stake in Grail during the 4th quarter worth about $33,000.

Analysts Set New Price Targets

Several research analysts recently issued reports on the stock. Wolfe Research assumed coverage on shares of Grail in a research report on Friday, November 15th. They issued a “peer perform” rating for the company. Morgan Stanley started coverage on Grail in a report on Wednesday, November 27th. They issued an “equal weight” rating and a $16.00 target price for the company.

Grail Company Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.